Related Experiment Video
Updated: May 4, 2026

A New Murine Model of Endovascular Aortic Aneurysm Repair
Published on: July 7, 2013
MMP-9: biomarker for abdominal aneurysm
C A Affirul1, I M Azim, H Hanafiah
1Surgery Department, Medical Faculty and Allied Health, Islamic Science University of Malaysia, 13th Floor, MPAJ Building, Kuala Lumpur.
Introduction:
Matrix Metalloproteinase 9 (MMP-9) has been shown to express significantly on organ tissue culture in Abdominal Aortic Aneurysm (AAA) patients. Prior studies have shown the correlation between MMP-9 concentration levels with AAA raising the probability of its usage as a biomarker in AAA disease. However, results of previous studies have been conflicting. The purpose of this study is to identify the correlation between MMP-9 concentration levels with AAA disease and further define the utility as a biomarker for our center population.
Materials And Methods:
This is prospective controlled trial. Peripheral venous blood sample is obtained from 20 patients with AAA and 36 normal control subjects. MMP-9 concentration levels were determined by an enzyme-linked immunosorbent assay and compared with subjects abdominal ultrasonography or computed tomography of abdomen.
Results:
Mean (± SE) MMP-9 was 23.94 ± 0.60 ng/mL in normal control subjects and 21.39 ± 1.03 ng/mL in patients with AAAs (p ← 0.05 versus normal control subjects). MMP-9 correlate significantly with AAA (p=0.004). There was no correlation of MMP-9 levels with age, gender, or other risk factors. The cutoff point is 12.54 for aorta size <3.0 cm. The sensitivity and specificity of MMP-9 were 60% and 64% respectively.
Conclusions:
MMP-9 levels correlate significantly with AAA with a cutoff point of 12.54. However, the utility of MMP-9 as a diagnostic test is limited due to low sensitivity and specificity. An elevated MMP-9 has limited use to predict the presence of AAA (positive predictive value: 60%) and a normal MMP-9 level was insufficient to determine the absence of AAA (negative predictive value: 36.1%).
Insights
Matrix Metalloproteinase 9 (MMP-9) levels correlate with Abdominal Aortic Aneurysm (AAA). However, MMP-9 has limited diagnostic utility for AAA due to low sensitivity and specificity.
Area of Science:
- Vascular Biology
- Biomarker Discovery
- Cardiovascular Research
Background:
- Matrix Metalloproteinase 9 (MMP-9) is significantly expressed in Abdominal Aortic Aneurysm (AAA) tissue.
- Previous studies suggest MMP-9 as a potential biomarker for AAA, but findings have been conflicting.
- This study investigates the correlation between MMP-9 levels and AAA to clarify its utility as a biomarker.
Purpose of the Study:
- To determine the correlation between Matrix Metalloproteinase 9 (MMP-9) concentration levels and Abdominal Aortic Aneurysm (AAA).
- To evaluate the utility of MMP-9 as a diagnostic biomarker for AAA in the studied population.
Main Methods:
- Prospective controlled trial involving 20 AAA patients and 36 healthy controls.
- MMP-9 concentrations measured using enzyme-linked immunosorbent assay (ELISA).
- Comparison of MMP-9 levels with abdominal imaging (ultrasonography or CT).
Main Results:
- MMP-9 levels were significantly correlated with AAA (p=0.004).
- Mean MMP-9 was 21.39 ± 1.03 ng/mL in AAA patients versus 23.94 ± 0.60 ng/mL in controls (p < 0.05).
- Sensitivity and specificity for MMP-9 as an AAA biomarker were 60% and 64%, respectively, with a cutoff of 12.54.
Conclusions:
- MMP-9 levels show a significant correlation with Abdominal Aortic Aneurysm (AAA).
- The diagnostic utility of MMP-9 for AAA is limited by its low sensitivity and specificity.
- MMP-9 has restricted value in predicting AAA presence or absence.
More Related Videos
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Role of Matrix Metalloproteases in Degradation of ECM
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

